The Effects of a Clean Room Sleeping Environment on Elemental and Chemical Concentrations in Children With Autism
1 other identifier
observational
10
1 country
1
Brief Summary
A child and their parent were asked to participate in a research project that sought to study whether sleeping in a very clean environment for 14 days improved the elimination of chemicals and metals from the child's body. The child had an approximately two hour evaluation to confirm his or her diagnosis of Autism or Pervasive Developmental Disorder. Not Otherwise Specified. When one of these diagnoses was confirmed the child was scheduled to spend 14 nights sleeping in a very clean environment in a specially created room at The Children's Institute. Several hours prior to the first night the child slept in the clean room the child's mother, father, or guardian filled out behavioral rating scales about the child with the assistance of the study's research coordinator. The child also had approximately two tablespoons of blood drawn from an arm and a few inch sample of hair was taken from the back of the child's head. The child and a parent or guardian arrived at The Children's Institute about one half hour prior to the child's normal time of settling for bed for 14 consecutive nights. The child and a parent or guardian slept in the clean room, wearing the provided very clean clothes and sleeping on special mattresses and sheets each night for 14 consecutive nights. The child and parent were observed by a nurse through a window during the time in the clean room. The child and parent participated in regular daytime activities during these 14 days of the study. On the morning after the last night the child and a parent or guardian slept in the clean room a parent or guardian filled out behavioral rating scales with the help of the research coordinator. Approximately two tablespoons of blood were drawn from an arm and a few inch sample of hair was obtained from the back of the child's head, at The Children's Institute or at home.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 16, 2014
CompletedFirst Posted
Study publicly available on registry
July 21, 2014
CompletedJuly 21, 2014
July 1, 2014
5 months
July 16, 2014
July 17, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in blood and hair elemental concentrations
Within one day pre and post 2 week experience of sleeping in the cleanroom
Secondary Outcomes (1)
Change of xenobiotic chemical concentrations
Within one day pre and post two week time the children sleep in the cleanroom
Other Outcomes (1)
Change of T and B cell subset results
Within one day pre and post the two week period the children sleep in the cleanroom
Study Arms (1)
Sleeping in a cleanroom
Each child and his or her parent slept in a cleanroom for two weeks. Within 24 hours pre and post this two week experience blood and hair samples were taken from the children and the parents filled out rating scales.
Interventions
Eligibility Criteria
Ten children confirmed to have autism through ADOS
You may qualify if:
- Diagnosis of autism or Pervasive Developmental Disorder . Not Otherwise Specified
- Age 3-21
- Delayed verbal ability and limited academic skill sets that are advancing slowly with current programming
You may not qualify if:
- Children who are behaviorally severely dysregulated
- Children with other chronic medical conditions that require close monitoring
- Children with uncontrolled seizure disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Children's Institutelead
- Duquesne Universitycollaborator
- Health Resources and Services Administration (HRSA)collaborator
Study Sites (1)
The Children's Institute
Pittsburgh, Pennsylvania, 15217, United States
Related Publications (1)
Faber S, Zinn GM, Boggess A, Fahrenholz T, Kern JC 2nd, Kingston HM. A cleanroom sleeping environment's impact on markers of oxidative stress, immune dysregulation, and behavior in children with autism spectrum disorders. BMC Complement Altern Med. 2015 Mar 19;15:71. doi: 10.1186/s12906-015-0564-0.
PMID: 25887094DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Scott Faber, MD
The Children's Institute
- PRINCIPAL INVESTIGATOR
Skip Kingston, Ph.D.
Duquesne University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Developmental Pediatrician
Study Record Dates
First Submitted
July 16, 2014
First Posted
July 21, 2014
Study Start
May 1, 2010
Primary Completion
October 1, 2010
Study Completion
October 1, 2010
Last Updated
July 21, 2014
Record last verified: 2014-07